New bill proposes the abolition of India’s troubled IPAB
Monsanto v Bowman: Supreme Court rejects “blame-the-bean” defence
India's Novartis ruling: the implications for patent owners
India’s Intellectual Property Appellate Board (IPAB) has affirmed that US agricultural company Monsanto cannot obtain a patent covering transgenic plants, two years after it was first rejected.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at firstname.lastname@example.org
ipab, monsanto, transgenic plants, bowman, plant varieties